Profile: Trevor Cook
|
Law Firm: | Bird & Bird |
|---|---|---|
| Office: |
Bird & Bird 15 Fetter Lane EC4A 1JP |
|
| City: | London | |
| Country: | England | |
| Tel: | +44 20 7415 6000 | |
| Fax: | +44 20 7415 6111 | |
| Email: | trevor.cook@twobirds.com |
Life Sciences
Biography: Life Sciences
Trevor Cook joined Bird & Bird in 1974 with a degree in chemistry from Southampton University. He was admitted as a solicitor in 1977, joining the intellectual property department of Bird & Bird, where since 1981 he has been a partner. He is president of the UK group of the AIPPI (International Association for the Protection of Industrial Property), and a member of the council of the Intellectual Property Institute.
In addition to numerous articles, Trevor has authored the following books: The Protection of Regulatory Data in the Pharmaceutical and Other Sectors (Sweet & Maxwell, 2000), A User's Guide to Patents (Butterworths, 2002, Tottel, 2007), A European Perspective as to the Extent to Which Experimental Use, and Certain Other Defences to Patent Infringement, Apply to Differing Types of Research (Intellectual Property Institute, 2006) and is working on a new edition of Pharmaceuticals Biotechnology and the Law (Macmillan, 1991, LexisNexis Butterworths - in press). He co-authors Practical Intellectual Property Precedents (Sweet & Maxwell, 1998 to date) with Audrey Horton. He is one of the general editors of The Modern Law of Patents (LexisNexis Butterworths, 2005). He contributes to the Chartered Institute of Patent Agents' European Patents Handbook (Sweet & Maxwell) and to Vaughan & Robertson's Law of the European Union (Oxford University Press). He also contributed to the third and fourth editions of the Chartered Institute of Patent Agents' Guide to the Patents Act 1977 (Sweet & Maxwell, 1990, 1995).
Significant reported cases in which he acted for one of the parties to the litigation include, in the area of regulatory law, the references to the European Court of Justice in R v Licensing Authority, ex parte Generics (UK), R v Licensing Authority, ex parte The Wellcome Foundation and R v Licensing Authority, ex parte Glaxo Operations UK and others [1999] 2 CMLR 181, R (On the application of Novartis Pharmaceuticals UK) v Licensing Authority & others [2004] 2 CMLR 26 and Approved Prescription Services v MCA, Lilly intervening, [2004] EUCECJ C-36/03. In patent litigation in the life sciences sector his cases include, Merrell Dow Pharmaceuticals v HN Norton [1996] RPC 76, Sepracor v Hoechst Marion Roussel [1999] FSR 746, Oxford Gene Technology v Affymetrix [2001] FSR 136, Lilly-ICOS v Pfizer [2001] FSR 16, Kirin-Amgen v Transkaryotic Therapies [2004] UKHL 46, Ranbaxy v Warner Lambert [2006] EWCA 876, Teva Pharmaceuticals v Merrell Pharmaceuticals & Others [2007] EWHC 2276 and Yeda Research and Development v Rhone-Poulenc Rorer International Holdings & another [2007] UKHL 43.
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our bookstore.
Other Practice Areas
Additional Practice Areas
Featured Articles
Articles By This Lawyer
Different Patent Systems, Similar Controversies
Patent litigation rarely makes it to the highest courts anywhere in the world, and the US Supreme Court is no exception. However, for the first time in a generation the Court is taking a real interest in patent matters. Some matters are still the subjects of petitions for certiorari requesting that the Court hear the case, with the Court having already granted certiorari in some, while in others it has requested a brief from the US Government, signalling its interest in the subject matter. Most such cases raise or touch on issues that are already, or are likely to become, matters of controversy in Europe, which makes it interesting to review them from such a perspective.